131 related articles for article (PubMed ID: 37088259)
21. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
[TBL] [Abstract][Full Text] [Related]
22. Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
Li Z; Li C; Yang D; Song J; Liu T; Zhou Z; Zhou L; Kang M
BMC Cancer; 2022 Jun; 22(1):616. PubMed ID: 35668431
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
[TBL] [Abstract][Full Text] [Related]
24. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
25. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Du C; Ying H; Zhou J; Hu C; Zhang Y
Int J Clin Oncol; 2013 Jun; 18(3):464-71. PubMed ID: 22527846
[TBL] [Abstract][Full Text] [Related]
26. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT.
Ozdemir S; Akin M; Coban Y; Yildirim C; Uzel O
Asian Pac J Cancer Prev; 2015; 16(5):1897-900. PubMed ID: 25773841
[TBL] [Abstract][Full Text] [Related]
27. A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model.
Zhang X; Yuan JJ; Ding JW; Zhang SH; Zhang ZL; Hu RH; Gong D; Hu JL; Tu ZW; Zeng L
Oncol Res Treat; 2022; 45(9):471-479. PubMed ID: 35705024
[TBL] [Abstract][Full Text] [Related]
28. Propolis mouthwash for preventing radiotherapy-induced mucositis in patients with nasopharyngeal carcinoma.
Hamzah MH; Mohamad I; Musa MY; Abd Mutalib NS; Siti-Azrin AH; Wan Omar WA
Med J Malaysia; 2022 Jul; 77(4):462-467. PubMed ID: 35902936
[TBL] [Abstract][Full Text] [Related]
29. Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.
Nugent M; Bryant V; Butcher C; Fisher H; Gill S; Goranova R; Hiu S; Lindley L; O'Hara J; Oluboyede Y; Patterson J; Rapley T; Robinson T; Rousseau N; Ryan V; Shanmugasundaram R; Sharp L; Smith Whelan R; Stocken DD; Ternent L; Wilson J; Walker J
Health Technol Assess; 2022 Dec; 26(46):1-172. PubMed ID: 36484364
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma].
Liu KQ; Jin F; Jiang H; Wu WL; Li YY; Long JH; Luo XL; Gong XY; Chen XX; Liu LN; Gan JY; Zhou JJ
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):133-138. PubMed ID: 32135648
[No Abstract] [Full Text] [Related]
31. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
33. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
34. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.
Wolff HA; Rödel RM; Gunawan B; Overbeck T; Herrmann MK; Hennies S; Hille A; Vorwerk H; Matthias C; Hess CF; Christiansen H
J Cancer Res Clin Oncol; 2010 Jan; 136(1):89-97. PubMed ID: 19618214
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883
[TBL] [Abstract][Full Text] [Related]
38. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma.
Zhang B; Li Y; Weng J; Huang B; Ban M; Lan G; Lu Y; Luo J; Qu S; Si Y
Technol Cancer Res Treat; 2021; 20():15330338211011975. PubMed ID: 33896244
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
